Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Malignant Lymphoma

Free Subscription 02.07.2018 3 Blood 1 Br J Haematol 1 Curr Treat Options Oncol 3 Haematologica 3 Leuk Lymphoma 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Blood

1. ALRABEH R, Hao S
   "Double-expressor" intravascular large B-cell lymphoma involving the female genital tract.
   Blood. 2018;131:2993.
   PubMed     Text format    
   
   
2. PATIL A, Manzano M, Gottwein E
   CK1alpha and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma.
   Blood. 2018 Jun 28. pii: blood-2018-01-828418. doi: 10.1182/blood-2018-01-828418
   PubMed     Text format     Abstract available
   
   
3. SAKAMOTO Y, Ishida T, Masaki A, Murase T, et al
   CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
   Blood. 2018 Jun 21. pii: blood-2018-02-835991. doi: 10.1182/blood-2018-02-835991
   PubMed     Text format    
   
   

   
   Br J Haematol

4. AZOULAY D, Nasser R, Sharon R, Simanovich L, et al
   Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine-induced peripheral neuropathy in patients with lymphoma.
   Br J Haematol. 2018 Jun 25. doi: 10.1111/bjh.15428.
   PubMed     Text format    
   
   

   
   Curr Treat Options Oncol

5. OLLILA TA, Olszewski AJ
   Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
   Curr Treat Options Oncol. 2018;19:38.
   PubMed     Text format     Abstract available
   
   

   
   Haematologica

6. EPSTEIN MM, Rosner B, Breen EC, Batista JL, et al
   Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies.
   Haematologica. 2018 Jun 21. pii: haematol.2017.183236.
   PubMed     Text format     Abstract available
   
   
7. RECASENS-ZORZO C, Cardesa-Salzmann T, Petazzi P, Ros-Blanco L, et al
   Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.
   Haematologica. 2018 Jun 28. pii: haematol.2017.180505.
   PubMed     Text format     Abstract available
   
   
8. AMBROSIO MR, Lazzi S, Lo Bello G, Santi R, et al
   MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients.
   Haematologica. 2018 Jun 28. pii: haematol.2018.195958.
   PubMed     Text format    
   
   

   
   Leuk Lymphoma

9. HUNTINGTON S, Keshishian A, McGuire M, Xie L, et al
   Costs of relapsed diffuse large B-cell lymphoma among Medicare patients.
   Leuk Lymphoma. 2018 Jun 25:1-8. doi: 10.1080/10428194.2018.1459613.
   PubMed     Text format     Abstract available
   
   
10. LONTOS K, Tsagianni A, Yuan JM, Normolle DP, et al
    Location matters in early stage nodal diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2018 Jun 22:1-4. doi: 10.1080/10428194.2018.1471600.
    PubMed     Text format    
    
    
11. WALSHAW RC, Illidge TM
    Revisiting the role of radiotherapy in Hodgkin lymphoma to augment systemic immunity.
    Leuk Lymphoma. 2018 Jun 22:1-2. doi: 10.1080/10428194.2018.1464160.
    PubMed     Text format    
    
    

    
    PLoS One

12. WU CH, Yang YH, Chen MR, Tsai CH, et al
    Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-kappaB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
    PLoS One. 2018;13:e0199779.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: